Intuitive Surgical Inc. (ISRG): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Intuitive Surgical ( ISRG) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.9%. By the end of trading, Intuitive Surgical rose $4.68 (1.2%) to $394.62 on light volume. Throughout the day, 249,138 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 582,500 shares. The stock ranged in a price between $389.55-$394.96 after having opened the day at $390.75 as compared to the previous trading day's close of $389.94. Other companies within the Health Care sector that increased today were: DexCom ( DXCM), up 21.3%, Thermogenesis Corporation ( KOOL), up 17.9%, Gentium SpA ( GENT), up 16.6% and OraSure Technologies ( OSUR), up 14.6%.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $15.6 billion and is part of the health services industry. Shares are down 19.9% year to date as of the close of trading on Wednesday. Currently there are 8 analysts that rate Intuitive Surgical a buy, 2 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, increase in net income and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, Pingtan Marine Enterprise ( PME), down 83.8%, Opexa Therapeutics ( OPXA), down 51.7%, Stereotaxis ( STXS), down 46.8% and Mast Therapeutics ( MSTX), down 40.9% , were all laggards within the health care sector with Seattle Genetics ( SGEN) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

The Method Behind My Investing Madness: Cramer's 'Mad Money' Recap (Wed 9/6/17)

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round